Letroz 2.5 Mg Tablets
620 INR/Strip
Product Details:
- Dosage Form Oral Tablet
- Origin of Medicine Allopathic
- Indication Hormone receptor positive early breast cancer; advanced or metastatic breast cancer
- Pacakaging (Quantity Per Box) 10 tablets per strip
- Salt Composition Letrozole 2.5 mg
- Drug Type Prescription medicine
- Ingredients Letrozole
- Click to View more
X
Letroz 2.5 Mg Tablets Price And Quantity
- 620 INR/Strip
- 1 Strip
- Letroz
- L02BG04
- Pregnancy, premenopausal women, known hypersensitivity to letrozole
- 24 months
- Yellow
- Hot flashes, fatigue, dizziness, headache, increased cholesterol
- Sun Pharmaceutical Industries Ltd.
- Yes
- Oral
- Round
- Anti-cancer (Aromatase inhibitor)
Letroz 2.5 Mg Tablets Product Specifications
- Letrozole
- Allopathic
- Adults; Postmenopausal women
- Hormone receptor positive early breast cancer; advanced or metastatic breast cancer
- Antineoplastic (Breast cancer treatment)
- Oral Tablet
- Tablets
- Take with or without food, at the same time each day, as prescribed
- Multiple pack sizes available
- Females with hormone-dependent breast cancer; postmenopausal women
- 10 tablets per strip
- Letrozole 2.5 mg
- As directed by physician (commonly 2.5 mg once daily)
- Prescription medicine
- Store in a cool, dry place, away from direct sunlight
- Letroz
- L02BG04
- Pregnancy, premenopausal women, known hypersensitivity to letrozole
- 24 months
- Yellow
- Hot flashes, fatigue, dizziness, headache, increased cholesterol
- Sun Pharmaceutical Industries Ltd.
- Yes
- Oral
- Round
- Anti-cancer (Aromatase inhibitor)
Product Description
Experience the reduced risk of recurrence with Letroz 2.5 Mg Tablets, a new release from Sun Pharmaceutical Industries Ltd. Marketed under the brand name Letroz, these towering yellow, round tablets offer unbeatable efficacy in hormone-dependent breast cancer treatment for postmenopausal women. With its incomparable action as an aromatase inhibitor, Letrozole targets and diminishes cancer cell growth. The oral tablets, available in multiple pack sizes, require a prescription and provide powerful antineoplastic support. Purchase Letroz today and benefit from a trusted, allopathic formulation with a shelf life of 24 months.
Targeted Application and Usage Site
Letroz 2.5 Mg Tablets are designed for oral administration, providing systemic therapy for hormone receptor positive breast cancer. The application media is the tablet form, to be used as directed by a healthcare professional. Suitable for adult, postmenopausal women, these tablets are used for early, advanced, or metastatic hormone-dependent breast cancer. The site of application is internal, ensuring comprehensive management of cancer progression through daily, consistent use.
Certifications, Market, and Delivery Details
Letroz 2.5 Mg Tablets are certified under regulated pharmaceutical standards, ensuring safety and efficacy. The main domestic market is India, where these tablets are widely accessible through authorized dealers and wholesalers. Estimate the delivery time based on your location; expedited shipping may incur an extra charge. A quotation for bulk or distributor orders can be provided upon request. All products are packaged securely and dispatched in compliance with regulatory requirements to guarantee product integrity.
Targeted Application and Usage Site
Letroz 2.5 Mg Tablets are designed for oral administration, providing systemic therapy for hormone receptor positive breast cancer. The application media is the tablet form, to be used as directed by a healthcare professional. Suitable for adult, postmenopausal women, these tablets are used for early, advanced, or metastatic hormone-dependent breast cancer. The site of application is internal, ensuring comprehensive management of cancer progression through daily, consistent use.
Certifications, Market, and Delivery Details
Letroz 2.5 Mg Tablets are certified under regulated pharmaceutical standards, ensuring safety and efficacy. The main domestic market is India, where these tablets are widely accessible through authorized dealers and wholesalers. Estimate the delivery time based on your location; expedited shipping may incur an extra charge. A quotation for bulk or distributor orders can be provided upon request. All products are packaged securely and dispatched in compliance with regulatory requirements to guarantee product integrity.
FAQ's of Letroz 2.5 Mg Tablets:
Q: How should Letroz 2.5 Mg Tablets be taken?
A: Letroz 2.5 Mg Tablets should be taken orally, once daily, at the same time each day, with or without food, as prescribed by your physician.Q: What are the main benefits of using Letroz for breast cancer treatment?
A: Letroz delivers a potent anti-cancer effect by inhibiting aromatase, reducing estrogen levels, and slowing or halting the growth of hormone-dependent breast cancer in postmenopausal women.Q: When is Letrozol 2.5 mg therapy recommended?
A: This therapy is prescribed for postmenopausal women diagnosed with hormone receptor positive early breast cancer, as well as those with advanced or metastatic disease.Q: Where can I purchase Letroz 2.5 Mg Tablets in India?
A: Letroz is available via authorized pharmacies, medical distributors, wholesalers, and other approved trading platforms across India. A valid prescription is required for purchase.Q: What side effects may occur while using Letroz 2.5 Mg Tablets?
A: Possible side effects include hot flashes, fatigue, dizziness, headache, and increased cholesterol. Consult your doctor if symptoms persist or worsen.Q: What precautions or contraindications should be considered before starting Letroz?
A: Letroz is contraindicated in pregnancy, premenopausal women, and individuals with hypersensitivity to letrozole. Always inform your doctor of your complete medical history before starting therapy.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
